Percepción de amenaza de la enfermedad renal crónica avanzada y su asociación con la sintomatología ansiosa y depresiva

Marco teórico: la percepción que tengan las personas con enfermedad crónica de su enfermedad, como es el caso de las personas con enfermedad renal crónica avanzada (ERCA), puede impactar notable-mente en su ajuste emocional. Una percepción más amenazante puede asociarse con más sintomato-logía emocional. El objetivo general fue valorar la sintomatología ansiosa y depresiva y la percepción de amenaza de la enfermedad de pacientes con ERCA.Método: 70 pacientes (80% varones), de entre 38-88 años (M=68,88; DT= 9,98) fueron evaluados mediante: la Escala Hospitalaria de Ansiedad y Depresión y la de Percepción de amenaza de la enferme-dad. Se realizaron análisis descriptivos, pruebas t, d de Cohen y correlaciones de Pearson.Resultados: un 41,79% presentaba sintomatología ansiosa y un 25,38% depresiva, percibían su enfermedad como moderadamente negativa. La sintomatología emocional fue mayor en las mujeres y se asoció con la percepción de amenaza de la enfermedad. Conclusiones: es necesario conocer los factores de riesgo para desarrollar programas de interven-ción que incidan en ellos y favorezcan la salud física y mental del paciente.PALABRAS CLAVE: Enfermedad Renal Crónica Avanzada, Ansiedad, Depresión.Theoretical framework: the perception that people with chronic disease have of their condition, such as people with advanced chronic kidney disease (AKD), can have a significant impact on their emotio-nal adjustment. A more threatening perception may be associated with more emotional symptoms. Methods: 70 patients (80% males) aged 38-88 years (M=68.88; TD=9.98) were evaluated using the Hospital Anxiety and Depression Scale and the Disease Threat Perception Scale. Descriptive analyses, t-tests, Cohen d-tests and Pearson correlations were performed.Results: 41.79% presented anxious symptomatology and 25.38% depressive, perceived their ill-ness as moderately negative. The emotional symptomatology was higher in women and was associa-ted with the perception of the threat of the disease. Conclusions: it is necessary to know the risk factors in order to develop intervention programs that affect them and favour the physical and mental health of the patien

Enfermedad renal crónica avanzada. Asociación entre ansiedad, depresión y resiliencia

Introduction: Advanced chronic kidney disease (ARKD) is associated with a greater likelihood of suffering from depressive and anxious symptomatology. However, resilience may cushion these effects. The overall objective was to assess the anxious and depressive symptomatology and resilience of patients with CKD. Methods: 70 patients (80% male) aged 38-88 years (M=68.88; TD=9.98) were evaluated using the Hospital Anxiety and Depression Scale and the Connor Davidson Resilience Scale. Descriptive analyses, t-tests, Cohen d-tests and Pearson correlations were performed. Results: 41.79% showed anxious symptomatology and 25.38% depressive, with moderate resilience scores. Emotional symptomatology was higher in women and was associated with lower resilience. Conclusions: it is necessary to know the risk and protection factors in order to carry out intervention programs that affect them and favor the physical and mental health of the patient.Introducción: el padecimiento de la enfermedad renal crónica avanzada (ERCA) se asocia con una mayor probabilidad de padecer sintomatología depresiva y ansiosa. No obstante, la resiliencia puede amortiguar estos efectos. El objetivo general fue valorar la sintomatología ansiosa, depresiva y la resiliencia de los pacientes con ERCA. Métodos: 70 pacientes (80 % varones), con edades entre 38-88 años (M=68,88; DT= 9,98) fueron evaluados mediante la Escala Hospitalaria de Ansiedad y Depresión y la de Resiliencia de Connor Davidson. Se realizaron análisis descriptivos, pruebas t, d de Cohen y correlaciones de Pearson. Resultados: un 41,79 % presentó sintomatología ansiosa y un 25,38 % depresiva, se observaron puntuaciones moderadas de resiliencia. La sintomatología emocional fue mayor en las mujeres y se asoció con una menor resiliencia. Conclusiones: es necesario conocer los factores de riesgo y protección para llevar a cabo programas de intervención que incidan en ellos y favorezcan la salud física y mental del paciente

Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain

Introduction: COVID-19 has a less severe course in children. In April 2020, some children presented with signs of multisystem inflammation with clinical signs overlapping with Kawasaki disease (KD), most of them requiring admission to the pediatric intensive care unit (PICU). This study aimed to describe the prevalence and clinical characteristics of KD SARS-CoV-2 confirmed and negative patients during the pandemic in Spain. Material and Methods: Medical data of KD patients from January 1, 2018 until May 30, 2020 was collected from the KAWA-RACE study group. We compared the KD cases diagnosed during the COVID-19 period (March 1-May 30, 2020) that were either SARS-CoV-2 confirmed (CoV+) or negative (CoV-) to those from the same period during 2018 and 2019 (PreCoV). Results: One hundred and twenty-four cases were collected. There was a significant increase in cases and PICU admissions in 2020 (P-trend = 0.001 and 0.0004, respectively). CoV+ patients were significantly older (7.5 vs. 2.5 yr) and mainly non-Caucasian (64 vs. 29%), had incomplete KD presentation (73 vs. 32%), lower leucocyte (9.5 vs. 15.5 × 109) and platelet count (174 vs. 423 × 109/L), higher inflammatory markers (C-Reactive Protein 18.5vs. 10.9 mg/dl) and terminal segment of the natriuretic atrial peptide (4,766 vs. 505 pg/ml), less aneurysm development (3.8 vs. 11.1%), and more myocardial dysfunction (30.8 vs. 1.6%) than PreCoV patients. Respiratory symptoms were not increased during the COVID-19 period. Conclusion: The KD CoV+ patients mostly meet pediatric inflammatory multisystem syndrome temporally associated with COVID-19/multisystem inflammatory syndrome in children criteria. Whether this is a novel entity or the same disease on different ends of the spectrum is yet to be clarified

Ground/space, passive/active remote sensing observations coupled with particle dispersion modelling to understand the inter-continental transport of wildfire smoke plumes

© . This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/During the 2017 record-breaking burning season in Canada/United States, intense wild fires raged during the first week of September in the Pacific northwestern region (British Columbia, Alberta, Washington, Oregon, Idaho, Montana and northern California) burning mostly temperate coniferous forests. The heavy loads of smoke particles emitted in the atmosphere reached the Iberian Peninsula (IP) a few days later on 7 and 8 September. Satellite imagery allows to identify two main smoke clouds emitted during two different periods that were injected and transported in the atmosphere at several altitude levels. Columnar properties on 7 and 8 September at two Aerosol Robotic Network (AERONET) mid-altitude, background sites in northern and southern Spain are: aerosol optical depth (AOD) at 440¿nm up to 0.62, Ångström exponent of 1.6–1.7, large dominance of small particles (fine mode fraction >0.88), low absorption AOD at 440¿nm (0.98). Profiles from the Cloud-Aerosol Lidar with Orthogonal Polarization (CALIOP) show the presence of smoke particles in the stratosphere during the transport, whereas the smoke is only observed in the troposphere at its arrival over the IP. Portuguese and Spanish ground lidar stations from the European Aerosol Research Lidar Network/Aerosols, Clouds, and Trace gases Research InfraStructure Network (EARLINET/ACTRIS) and the Micro-Pulse Lidar NETwork (MPLNET) reveal smoke plumes with different properties: particle depolarization ratio and color ratio, respectively, of 0.05 and 2.5 in the mid troposphere (5–9¿km) and of 0.10 and 3.0 in the upper troposphere (10–13¿km). In the mid troposphere the particle depolarization ratio does not seem time-dependent during the transport whereas the color ratio seems to increase (larger particles sediment first). To analyze the horizontal and vertical transport of the smoke from its origin to the IP, particle dispersion modelling is performed with the Hybrid Single Particle Lagrangian Integrated Trajectory Model (HYSPLIT) parameterized with satellite-derived biomass burning emission estimates from the Global Fire Assimilation System (GFAS) of the Copernicus Atmosphere Monitoring Service (CAMS). Three compounds are simulated: carbon monoxide, black carbon and organic carbon. The results show that the first smoke plume which travels slowly reaches rapidly (~1¿day) the upper troposphere and lower stratosphere (UTLS) but also shows evidence of large scale horizontal dispersion, while the second plume, entrained by strong subtropical jets, reaches the upper troposphere much slower (~2.5¿days). Observations and dispersion modelling all together suggest that particle depolarization properties are enhanced during their vertical transport from the mid to the upper troposphere.Peer Reviewe